Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Bahija Jallal

Bahija Jallal is recorded as CEO and Board Member at Immunocore Holdings plc (IMCR). Earlier roles on record: Board Member at Guardant Health, Inc. (GH) until June 15, 2022. The proxy statement of Immunocore Holdings plc reports total compensation of $10,885,268 for Bahija Jallal in fiscal 2025, including a base salary of $765,000. Disclosed compensation is on record for 5 fiscal years. Bahija Jallal has spoken on 8 earnings calls across 1 company, most recently for Immunocore Holdings plc on February 25, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Immunocore Holdings plc

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Immunocore Holdings plc (IMCR) $765,000 $10,885,268
2024 Immunocore Holdings plc (IMCR) $760,000 $12,852,234
2023 Immunocore Holdings plc (IMCR) $735,000 $11,678,834
2022 Immunocore Holdings plc (IMCR) $700,000 $8,008,503
2021 Immunocore Holdings plc (IMCR) $700,000 $34,783,285

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.